Abstract
To induce tolerance in patients receiving allografts has been a goal of transplantation research in the past 50 years. However, with increasing experience of patient management and new drug regimens, it is difficult to imagine that a protocol to produce tolerance between any possible donor and recipient would be feasible in the foreseeable future. We already have full tolerance whenever there is a successful bone marrow transplant, traditionally the whole immune system is destroyed by irradiation and/or drugs and replaced with the donor's marrow. Success usually requires close matching of HLA antigens between donor and recipient and usually in fact the use of bone marrow from an HLA identical sibling.
Keywords: organ
Most Viewed Current Articles
26 Jan 2022 : Review article
Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive ModelsDOI :10.12659/AOT.934924
Ann Transplant 2022; 27:e934924
24 Aug 2021 : Review article
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original article
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860